Subscribe to newsletter
Facebook
Linkedin
X
Youtube
Linkedin
Twitter
Youtube
Facebook
Thu 30 April 2026
Subscribe to DDD newsletter
Search
Discovery
Phase 1-2
Phase 3
IND-enabling
Commercial
Modality choices (small molecules, biologics, ATMPs)
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Latest posts
Events and Conferences
Interphex Week Tokyo 2026 organises show floor around manufacturing, packaging, inspection and digital production technologies
Commercial
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers
Funding & Finance
Evotec announces chief financial officer transition
CDMO strategy
PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities
Discovery
ImmunoForge to accelerate central nervous system drug development with innovative blood-brain barrier shuttle platform
Load more